XORTX Therapeutics Inc banner

XORTX Therapeutics Inc
F:ANU

Watchlist Manager
XORTX Therapeutics Inc Logo
XORTX Therapeutics Inc
F:ANU
Watchlist
Price: 2.33 EUR 4.48% Market Closed
Market Cap: €517.5k

Wall St Price Targets

ANU Price Targets Summary
XORTX Therapeutics Inc

There are no price targets for ANU.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
XORTX Therapeutics Inc Competitors:
Price Targets
BTDR
Bitdeer Technologies Group
24% Upside
JNJ
Johnson & Johnson
11% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for XORTX Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for XORTX Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ANU's stock price target?
Not Available

ANU does not have any price targets made by Wall Street professionals.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett